Institute for Stem Cell Biology and Regenerative Medicine
Showing 1-38 of 38 Results
-
Heather Gentner
Director of Finance and Administration (SoM), Stem Cell Bio Regenerative Med Institute
Current Role at StanfordI am the Director of Finance and Administration for the Institute for Stem Cell Biology and Regenerative Medicine (ISCBRM) in the School of Medicine. I oversee and carry out administrative and financial related functions for the department.
-
Wan-Jin Lu
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioDr. Wan-Jin Lu is a Research Scientist in Dr. Phil Beachy's lab. Wan-Jin grew up in Taiwan, obtained her B.S. in Zoology at National Taiwan University and completed her PhD in Genetics and Development at UT Southwestern in the lab of Dr. John Abrams. Her Ph.D. research involved the identification of the evolutionary conserved function of the tumor suppressor gene p53 that ensures the quality control of germ cells. She then moved to the Bay Area, where she was a Damon Runyon Postdoctoral Fellow in the Institute of Stem Cell Biology and Regenerative Medicine in the Beachy lab. Her work currently focuses on understanding the function of Hedgehog signaling in taste receptor cell homeostasis and delineating the mechanisms of taste receptor regeneration after chemotherapy-induced loss.
Since 2017, she has been collaborating with Tabula Muris And Tabula Sapiens Consortium to investigate taste receptor stem cell renewal and regeneration in the Beachy lab. Her work has received funding support from California Institute of Regenerative Medicine (CIRM), Thomas and Stacey Siebel Foundation, and NIH (R21 and R01). -
Gernot Neumayer
Senior Research Scientist, Stem Cell Bio Regenerative Med Institute
Current Role at StanfordSenior Scientist
-
Kouta Niizuma
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioI am a Research Scientist in Prof. Hiromitsu Nakauchi's laboratory at Stanford University. I obtained my PhD in Immunology from the University of Tsukuba, Japan. During my doctoral studies in Prof. Akira Shibuya's laboratory, I focused on the characterization of cell surface receptors expressed on immune cells. I successfully cloned a novel human immunoglobulin-like receptor, CD300H, and established a specific monoclonal antibody. My research demonstrated that CD300H is expressed on a subset of human monocytes and dendritic cells and plays a crucial role in enhancing inflammation by promoting the production of inflammatory cytokines and chemokines.
During my PhD, I also studied as a visiting scholar in Prof. Lewis L. Lanier's laboratory at UCSF, where I investigated the role of the activating receptor NKG2D on NK cells in viral immunity.
Since May 2018, I have been a member of the Nakauchi lab. My current research focuses on the development of new immunotherapies using myeloid cells derived from iPS cells, the generation of monoclonal antibodies, and hematopoietic stem cell biology.
